Search results | News and features | University of Bristol

International

Screening with a PSA test has a small impact on prostate cancer deaths but leads to overdiagnosis 6 April 2024 The largest study to date investigating a single invitation to a PSA blood test* to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and missed early detection of some aggressive cancers. The CAP trial, published in the Journal of the American Medical Association (JAMA) and carried out by researchers from the universities of Bristol, Oxford and Cambridge, involved over 400,000 men aged 50-69. Just under half received a single invitation for a PSA test as part of the trial.
Investigation exposing huge surge of gambling marketing at start of Premier League season prompts urgent call to kick 鈥榦ut of control鈥� industry into touch 27 September 2024 New research reveals gambling messages during the opening weekend of this season鈥檚 football Premier League have almost trebled since last year, putting fans including children at risk.
Last Ice Age has shaped sharks across Europe 12 November 2014 Shark populations in the Mediterranean are highly divided, an international team of scientists, led by Dr Andrew Griffiths of the University of Bristol, has shown.
Pioneering research sheds light on how babies and young children understand the art of pretence 15 August 2024 Babies recognise pretence and around half of children can pretend themselves by 12 months, new research has found.
Gum disease having devastating impact on general health and well-being warn dentists 19 March 2018 A new report has revealed that the number of people affected by tooth decay and gum disease is having a widespread and devastating impact not only on patients mouths but also on their general health and wellbeing, particularly in the older population.
ProtecT trial receives award for pioneering research demonstrating the safety of active surveillance 13 August 2024 A study to find out the best ways of treating prostate cancer has been named the 2024 recipient of the Active Surveillance Patients International (ASPI) Special Award. The ProtecT trial, led by the Universities of Bristol and Oxford, received the award for game-changing research in the development of the active surveillance approach to managing low-risk prostate cancer. Their research has proved active monitoring in patients with lower-risk prostate cancer was as safe as aggressive treatments.
Donate political leaflets to Bristol鈥檚 unique election archive 27 June 2024 With the July 4 General Election less than a week away, political parties are ramping up their campaigns and delivering plenty of promotional literature through letterboxes across the country in a bid to secure precious votes.
New study identifies two proteins that may contribute to stroke recurrence 22 July 2024 People who experience an arterial ischemic stroke (AIS) or transient ischemic stroke (TIA) are at an increased risk of suffering a second stroke or other major adverse cardiovascular event (MACE), making it critically important to identify risk factors and treatments to prevent these subsequent occurrences. The new study, led by Boston University School of Public Health (BUSPH) and University of Bristol researchers, has identified new genetic and molecular risk factors that may reveal new pathways for treating patients after they experience their first stroke.
Prescription painkiller misuse and addiction are widespread in chronic pain patients 8 August 2024 A new scientific review of 148 studies enrolling over 4.3 million adult chronic pain patients treated with prescription opioid painkillers has found that nearly one in ten patients experiences opioid dependence or opioid use disorder. The University of Bristol-led study, published in Addiction today [8 August], also found nearly one in three shows symptoms of dependence and opioid use disorder.
Majority of female cancer survivors at low risk of developing most obstetric complications 26 June 2024 The majority of women who have survived a cancer diagnosed age 15-39 are at low risk of obstetric complications, a new study has found.

Search

News categories

Date

View the for public events and lectures run by the University.